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Abstract
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: ‘Does the use of bilat-
eral mammary artery grafts compared with the use of a single mammary artery graft offer a long-term survival beneﬁt in patients undergo-
ing coronary artery bypass surgery?’ Altogether 214 papers were found using the reported search, of which 13 represented the best
evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant
outcomes and results of these papers are tabulated. All the included studies were follow-up studies; eight studies used prospective data
collection, and ﬁve studies collected the study data retrospectively. No randomized controlled trials were found. Nine of the 13 included
papers used a propensity-score-matched comparison of the survival of bilateral mammary artery graft [or, bilateral internal thoracic artery
(BITA) graft] patients vs single mammary artery graft [or, single internal thoracic artery (SITA) graft] patients. These studies consistently
showed an enhanced survival of BITA patients compared with propensity-score-matched SITA patients. Three of the 13 included papers
used Cox proportional hazards regression analysis to compare survival of BITA vs SITA patients; one larger study showed better crude sur-
vival of BITA patients, but did not identify BITA grafts as independent predictor of enhanced survival. The remaining two studies also did
not identify BITA grafts as independent predictor of enhanced survival. One study only presented crude survival estimates of BITA vs SITA
patients and therefore was of limited informative value. We conclude that the use of BITA grafts seems to offer a long-term survival beneﬁt
compared with a SITA graft for patients undergoing coronary artery bypass grafting surgery. Although randomized evidence is lacking, ob-
servational evidence supporting this hypothesis is mounting.
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INTRODUCTION
A best evidence topic was constructed according to a structured
protocol. This is fully described in the ICVTS [1].
THREE-PART QUESTION
In patients undergoing coronary bypass grafting surgery, is the use
of bilateral mammary artery bypass grafts superior to the use of
a single mammary artery bypass graft in terms of long-term
survival?
CLINICAL SCENARIO
You are scheduled to perform an elective coronary bypass grafting
procedure and discuss the case with your resident the night
before. You plan to revascularize the anterior wall with the left in-
ternal mammary artery (LIMA), and discuss the possibilities of
revascularization of the lateral and inferior wall with your resident.
He suggests using a second mammary artery graft. You ask him to
do a literature search on the latest research on long-term survival
of this procedure compared with the use of a saphenous vein graft
(SVG).
SEARCH STRATEGY
Medline (PubMed interface) was searched from 1950 until
January 2013, using the following criteria: ‘Coronary Artery
Bypass’[Mesh] AND ‘bilateral mammary artery’ AND ‘Mortality’.
SEARCH OUTCOME
Two hundred and fourteen papers were found using the reported
search. Two authors (T.S. and G.T.L.K.) independently assessed all
the papers and selected 13 papers that provided the best evi-
dence to answer the question. These are presented in Table 1. We
used the meta-analysis performed in 2001 by Taggart et al. [2] as a
starting point and thus excluded all papers that were published
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Table 1: Best evidence papers
Author, date, journal
and country
Study type
(level of evidence)
Patient group Outcomes Key results Comments
Grau et al. (2012),
Eur J Cardiothorac
Surg [3], USA
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Elective CABG patients: BITA
n = 1459, SITA (LIMA + SVG)
n = 4854
Propensity-score-matched groups:
BITA n = 928, SITA n = 928
Mean follow-up 9 ± 0.5 years
15-year survival BITA 79% vs SITA 61%,
P < 0.0001
Enhanced long-term survival of BITA
patients, compared with propensity-
score-matched SITA patients
Galbut et al. (2012),
J Thorac Cardiovasc
Surg [4], USA
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Elective and non-elective CABG
patients, stratified by LVEF:
BITA n = 2197, SITA n = 2340
Long-term survival,
LVEF < 30%
7 years: BITA 51.7 ± 5.4%
vs SITA 57.0 ± 5.3%
14 years: BITA
26.6 ± 5.5% vs SITA
26.6 ± 5.1%
P = 0.934
Enhanced long-term survival of BITA
patients compared with
propensity-score-matched SITA
patients, with normal or reduced
ejection fraction, but not in patients
with EF < 30%
Long-term survival,
LVEF 30–50%
10 years: BITA
62.0 ± 2.3% vs SITA
57.7 ± 2.3%
20 years: BITA
33.1 ± 3.4% vs SITA
19.2 ± 2.5%
P = 0.016
Long-term survival,
LVEF > 50%
14 years: BITA
59.4 ± 1.5% vs SITA
54.4 ± 1.5%
28 years: BITA
19.5 ± 3.4% vs SITA
14.4 ± 4.2%
P = 0.012
Locker et al. (2012),
Circulation [5], USA
Retrospective
follow-up study
Comparison of
propensity-score-
matched groups and
adjustment for
differences between
groups by Cox
model
(level IIa)
Isolated primary CABG patients
BITA/SVG n = 589, BITA-only
n = 271, BITA/RA n = 147, LITA/RA
n = 169, BITA/RA/SVG n = 8, RITA/
RA n = 2, BITA/GEA n = 1
Multiple arterial grafts
(i.e. BITA, BITA/RA,
LITA/RA) vs SITA,
propensity-score-
matched survival
Multiple arterial grafts 83
and 70% vs SITA 80 and
60% at 10- and 15-year
follow-up, respectively,
P = 0.0025
BITA grafts conferred a survival benefit
at 15 years compared with SITA grafts
15-year survival
BITA-only vs SITA (crude
Kaplan–Meier estimates)
BITA 74.5% (95%
confidence interval (CI)
63.1–88.1%) vs SITA
36.3% (95% CI
34.6–38.1%)
15-year survival BITA/
SVG vs SITA (crude
Kaplan–Meier estimates)
BITA 75.8% (95% CI
69.8–82.3%) vs SITA
36.3% (95% CI
34.6–38.1%)
Adjusted survival benefit
BITA-only vs SITA (Cox
model)
Hazard ratio (HR) = 0.80
(95% CI 0.55–1.16,
P = 0.237)
Adjusted survival benefit
BITA/SVG vs SITA/(Cox
model)
HR = 0.73 (95% CI
0.57–0.94, P = 0.015)
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Table 1: (Continued)
Author, date, journal
and country
Study type
(level of evidence)
Patient group Outcomes Key results Comments
Kinoshita et al.
(2012), Ann Thorac
Surg [6], Japan
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Isolated CABG patients ages 70
years or greater
SITA n = 247, BITA n = 244
Propensity-score-matched groups:
217 pairs
Propensity-matched
5-year survival estimates
BITA 86.4 ± 3.2% vs SITA
73.5 ± 3.9% (P = 0.01)
In elderly patients, BITA grafting is
associated with a lower 5-year
mortality compared with SITA grafting
Adjusted survival benefit
BITA vs SITA (Cox model)
HR = 0.56 (95% CI
0.31–0.99, P = 0.04)
Kurlansky et al.
(2010), Ann Thorac
Surg [7], USA
Retrospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Isolated CABG patients
BITA n = 2215, SITA n = 2369
Propensity-score-matched groups:
BITA n = 2197, SITA n = 2197
Mean follow-up 11.5 years
Crude survival estimates
at 15 years
BITA 53.5 ± 1.2% vs SITA
37.5 ± 1.1% (P < 0.001)
BITA grafting offers a long-term
survival advantage over SITA grafting
Crude survival estimates
at 25 years
BITA 28.6 ± 2.2% vs SITA
15.7 ± 2.0% (P < 0.001)
Propensity-matched
groups survival at 15
years
BITA 53.5 ± 1.2% vs SITA
39.0 ± 1.1% (P = 0.001)
Propensity-matched
groups survival at 25
years
BITA 28.5 ± 2.2% vs SITA
16.5 ± 2.1% (P = 0.001)
Kieser et al. (2011),
Ann Thorac Surg [8],
Canada
Prospective
follow-up study
Adjustment for
differences between
groups by Cox
model (level IIa)
Isolated CABG patients
BITA n = 1038, SITA n = 4029
Mean follow-up 7.1 years
1-year mortality BITA 2.4% vs SITA 4.3% vs
vein-only 8.2%
Better crude survival for BITA patients.
However, after adjustment not
significant anymore. Maybe age is an
effect modifier. BITA seems
reasonable in patients <70 years of
age
Crude survival benefit of
BITA vs SITA
HR 0.46 (95% CI
0.37–0.57, P < 0.0001)
Adjusted survival benefit
BITA vs SITA (Cox model)
HR 0.87 (95% CI 0.69–
1.08, P = 0.2). Spline
analysis of plotting HR
(BITA vs SITA) against age
suggested potential
survival benefit of BITA
in patients <69.9 years of
age
Mohammadi et al.
(2008), Eur J
Cardiothorac
Surg [9], Canada
Prospective
follow-up study
Adjustment for
differences between
groups by Cox
model
(level IIa)
Primary isolated CABG patients
BITA n = 1277, SITA n = 9566
Mean follow-up 5.7 ± 3.7 years
Crude survival
(at 5, 7 and 10 years,
respectively)
98.4, 97.8 and 96.5% for
BITA vs 96.6, 94.3 and
88.9% for SITA
(P < 0.0001)
Additional survival benefit of BITA
compared with SITA. This survival
benefit decreases gradually with age,
and is lost after 60 years of age
Adjusted survival benefit
BITA vs SITA (Cox model)
HR = 0.02 (95% CI
0.002–0.40, P = 0.009)
Adjusted survival benefit
per age category (Cox
model)
Survival benefit of BITA
vs SITA gradually
decreases with age, and
is lost after 60 years of
age
Continued
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Table 1: (Continued)
Author, date, journal
and country
Study type
(level of evidence)
Patient group Outcomes Key results Comments
Di Mauro et al.
(2005), Ital Heart J
[10], Italy
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Primary CABG patients <70 years
of age
Propensity-score-matched groups:
BITA n = 476, SITA n = 476
Mean follow-up 8.8 ± 4.0 years
10-year survival BITA 92.4 ± 2.1%, SITA
87.5 ± 3.5%, P = 0.0216
BITA patients had better 10-year
survival compared with
propensity-score-matched SITA
patients
Lytle et al. (2004),
Ann Thorac Surg
[11], USA
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Primary CABG patients
BITA n = 1152, SITA n = 1152
Mean follow-up 16.2 years
Long-term survival BITA vs SITA, 89 vs 87%,
81 vs 78%, 67 vs 58% and
50 vs 37% at 7-, 10-, 15-
and 20-year follow-up,
respectively, P < 0.0001
BITA patients had better long-term
survival compared with
propensity-score-matched SITA
patients
Calafiore et al.
(2004), Eur J
Cardiothorac
Surg [12], Italy
Prospective
follow-up study
Comparison of
propensity-score-
matched groups
(level IIa)
Primary CABG patients <75 years
BITA n = 1026, SITA n = 576
Propensity-score-matched pairs:
BITA n = 570 vs SITA n = 570
Mean follow-up 7.3 ± 4.8 years
Propensity-matched
10-year survival
BITA 90.5 ± 2.8 vs SITA
87.1 ± 1.6, P = 0.0696
No significant survival benefit in
propensity-matched groups of BITA vs
SITA patients. BITA patients had better
long-term freedom from cardiac
death, as well as freedom from events
10-year freedom from
cardiac death
BITA 96.5 ± 0.8% vs SITA
91.3 ± 1.4%, P = 0.0288
10-year freedom from
acute myocardial
infarction (AMI)
BITA 98.0% ± 0.6 vs SITA
94.3 ± 1.2%, P = 0.0180
10-year freedom from
AMI in grafted area
BITA 98.4% ± 0.6 vs SITA
94.7 ± 1.1%, P = 0.0057
10-year freedom from
target cardiac events
BITA 93.9 ± 1.1% vs SITA
86.3% ± 1.8, P = 0.0388
Hirotani et al. (2003),
Ann Thorac Surg
[13], Japan
Retrospective
follow-up study
Comparison of crude
survival estimates
(level IIa)
Primary CABG in diabetic patients
(both insulin dependent and
non-insulin dependent)
BITA n = 179, SITA n = 124
Long-term survival No differences in
long-term survival
between BITA and SITA
No difference in long-term mortality
between BITA patients and SITA
patients
These results should be interpreted
with caution as only crude survival
estimates were compared
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before 2001. We included studies in which at least 100 patients in
each arm were followed up at least for 4 years. The variables age,
sex, ventricular function and diabetes status needed to be
reported for each study arm separately.
RESULTS
Grau et al. [3] performed a prospective follow-up study of patients
undergoing elective coronary artery bypass surgery (CABG), and
made 928 propensity-score-matched pairs of bilateral internal
thoracic artery (BITA) vs single internal thoracic artery (SITA)
patients. During a mean follow-up of 9 years, BITA patients
showed to have an enhanced 15-year survival compared with
propensity-score-matched SITA patients.
Galbut et al. [4] performed a prospective follow-up study of
both elective and non-elective CABG patients and made
propensity-score-matched groups. Patients were stratiﬁed by left
ventricular ejection fraction (LVEF). Long-term survival was better
among BITA patients with normal or reduced left-ventricular ejec-
tion fraction (respectively LVEF > 50% and LVEF 30–50%), but not
among patients with a LVEF of < 30%.
Locker et al. [5] performed a retrospective analysis of patients
undergoing CABG. At 10- and 15-years of follow-up, patients with
multiple arterial grafts (i.e. BITA, BITA and radial artery (RA), or
SITA and RA) had a signiﬁcantly better survival compared with
propensity-score-matched SITA patients. Although no separate
analysis of BITA grafts (i.e. without patients receiving the combin-
ation SITA + RA) compared with propensity-score-matched SITA
patients is presented, the crude survival estimates of BITA-only
patients and BITA + SVG patients are both signiﬁcantly better than
SITA patients. Also, the Cox proportional hazards model showed
that both the use of BITA-only and of BITA + SVG were associated
with a signiﬁcantly lower risk of early mortality compared with
SITA.
Kinoshita et al. [6] performed a propensity-score-matched ana-
lysis in patients ≥70 years of age and showed that the use of BITA
grafts is associated with signiﬁcantly lower mortality at 5-years of
follow-up in these patients.
Kurlansky et al. [7] performed a retrospective analysis of 2197
propensity-score-matched pairs of BITA and SITA patients and
showed that BITA grafts offered a long-term survival beneﬁt com-
pared with SITA grafts (at 15- and 25-years of follow-up).
Kieser et al. [8] performed a prospective follow-up study
showing that crude mortality was lower in BITA patients compared
Table 1: (Continued)
Author, date, journal
and country
Study type
(level of evidence)
Patient group Outcomes Key results Comments
Endo et al. (2003),
Circulation [14],
Japan
Retrospective
follow-up study
Adjustment for
differences between
groups by Cox
model
(level IIa)
Primary CABG patients, studied in
subgroups of diabetic patients and
non-diabetic patients
Diabetic patients: BITA n = 190,
SITA n = 277. Non-diabetic
patients: SITA n = 411, BITA n = 253
Median follow-up 8.1 years
Crude 10-year survival
among diabetic patients
BITA 80.2 ± 3.8% vs SITA
75.4 ± 3.0%, P = 0.46
BITA grafting is not significantly better
in reducing all-cause mortality than
SITA grafting when assessing the Cox
proportional hazards estimates10-year survival among
diabetic patients with
LVEF > 40%
BITA 87.8 ± 3.5% vs
75.2 ± 3.4%, P = 0.04
Adjusted survival benefit
BITA (Cox model) among
diabetic patients
HR = 0.91 (95% CI
0.597–1.4, P = 0.6)
Adjusted survival benefit
BITA (Cox model) in
diabetic patients with
LVEF > 40%
HR = 0.61 (95% CI
0.36–1.067, P = 0.08)
Endo et al. (2001),
Circulation [15],
Japan
Retrospective
follow-up study
Adjustment for
differences between
groups by Cox
model
(level IIa)
Isolated CABG patients
BITA n = 443, SITA n = 688
Median follow-up 6.15 years
7-year all death-free rate BITA 88.7 ± 1.9% vs SITA
86.9 ± 1.4%, P = 0.6
No differences in mortality between
BITA and SITA patients
7-year re-CABG free rate BITA 99.5% vs SITA
97.3%, P = 0.0256
Adjusted survival benefit
BITA vs SITA (Cox model)
HR = 0.95, 95%
CI 0.67–1.35
Survival data are presented as Kaplan–Meier survival estimate ± standard error of the mean, or as Kaplan–Meier survival estimate with corresponding 95% CI.
AMI: acute myocardial infarction; BITA: bilateral internal thoracic artery; CABG: coronary artery bypass grafting; CI: confidence interval; GEA: gastroepiploic
artery; HR: hazard ratio; LITA: left internal thoracic artery; LVEF: left ventricular ejection fraction; SVG: saphenous vein graft; MI: myocardial infarction; RA:
radial artery.
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with SITA patients. However, the adjusted survival beneﬁt was
non-signiﬁcant. Subanalyses of the data showed that age was a
potential effect modiﬁer and that BITA grafting might offer a sur-
vival beneﬁt in patients <70 years of age.
Mohammadi et al. [9] performed a prospective follow-up study
of 1277 BITA patients and 9566 SITA patients. BITA grafting was
associated with a signiﬁcantly lower risk of early mortality, and this
survival beneﬁt seemed to be lost in patients older than 60 years
of age.
Di Mauro et al. [10] showed in a prospective manner that BITA
patients had a signiﬁcant better 10-year survival compared with
propensity-score-matched SITA patients.
Lytle et al. [11] studied 1152 propensity-score-matched pairs of
BITA vs SITA patients over a mean period of 16.2 years and found
that survival was signiﬁcantly better among BITA patients com-
pared with SITA patients.
Calaﬁore et al. [12] found no signiﬁcant survival beneﬁt of BITA
grafting at 10-year follow-up.
Hirotani et al. [13] found no difference in long-term mortality
between BITA and SITA patients with diabetes. However, this ana-
lysis has the limitation that only crude mortality rates were
assessed in a small group of patients (BITA n = 179 vs SITA n = 124).
Endo et al. [14] performed a retrospective analysis among
diabetic CABG patients. The data were stratiﬁed according to left-
ventricular ejection fraction. At 7-years of follow-up, crude
mortality rates were similar between BITA and SITA patients. Cox
proportional hazards analysis showed a non-signiﬁcant beneﬁt of
BITA grafts when assessing all-cause mortality. However, BITA
grafts conferred a beneﬁt when assessing the composite end-
point of death, redo coronary surgery or myocardial infarction.
In 2001, Endo et al. [15] found no survival beneﬁt of BITA graft-
ing among more than 1000 patients undergoing CABG.
CLINICAL BOTTOM LINE
Although methodological issues make head-to-head comparison
difﬁcult, observational studies suggest that the use of BITA grafts
seems to offer a long-term survival beneﬁt compared with SITA
for patients undergoing CABG surgery. Although randomized evi-
dence is currently lacking, observational evidence supporting this
hypothesis is mounting.
Conﬂict of interest: none declared.
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We read with great interest the paper by Smith et al. regarding the long-term sur-
vival beneﬁt of the usage of bilateral internal mammary artery (BIMA) grafts in coron-
ary revascularization surgery [1]. They included in their results 13 follow-up studies
published after 2001. However, we found one additional relevant article investigating
the long-term outcomes associated with BIMA grafting compared with single internal
mammary artery (SIMA) among diabetic patients [2]. We would like to take this op-
portunity to brieﬂy extract the relevant information from the above-mentioned
study and to add a short comment on this salient subject.
Puskas et al. [2] conducted a retrospective cohort analysis by extracting data from
the Society of Thoracic Surgeons database at a single referral academic centre. They
included a total of 3527 coronary artery bypass grafting procedures (BIMA n = 812,
SIMA n = 2715). After adjustment for differences between groups by the Cox model,
BIMA grafting portended a 35% reduction in the hazard of long-term death at 8
years of follow-up (adjusted hazard ratio, 0.65; 95% CI, 0.48 to 0.88, P = 0.006). The
authors concluded that the usage of BIMA grafting provides signiﬁcant beneﬁt in late
survival compared with SIMA grafting in both diabetic and non-diabetic patients.
BIMA grafting should be performed whenever patient risk factors and comorbidities
allow an acceptable risk of deep sternal wound infection.
As rightly outlined by the authors, all these studies are follow-up studies. However,
only one randomized trial comparing these two techniques (ART Arterial
Revascularization Trial) [3] is currently under way in Europe that can broaden our
understanding. ART primary outcome is survival at 10 years; therefore the results
should be available by 2018. Until that date the debate will continue. This uncertainty
has been reﬂected in the rate of adoption of BIMA grafting, the rate of use of the
technique varies from 4% in North America to 10% in Europe [4]. The major reasons
for not using BIMA grafts are the lack of solid evidence of beneﬁts and the increased
rate of sternal wound infection, particularly in diabetics. Of note, in the SYNTAX
study [5], BIMA grafting was used in a relatively higher percentage of 28% of patients.
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